Trials / Recruiting
RecruitingNCT06630455
Meu-cinn for Gastric Mucosal Health in Adults With Functional Dyspepsia
Effects of Meu-cinn on Promoting Gastric Mucosal Health in Adults With Functional Dyspepsia: A Randomized, Double-blind, Placebo-controlled Clinical Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Pusan National University Yangsan Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This clinical trial aims to determine whether Meu-cinn promotes gastric mucosal health in adults with functional dyspepsia and to assess its safety. The main questions are: * Does Meu-cinn promote gastric mucosal health in participants? * What side effects occur when participants take Meu-cinn?
Detailed description
Researchers will compare Meu-cinn to placebo to evaluate their effectiveness in promoting gastric mucosal health. Participants will: * Take Meu-cinn or a placebo daily for 8 weeks. * Visit the clinic at 1, 2, 4, and 8 weeks for checkups and tests.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Meu-cinn | Meu-cinn 250 mg/day for 8 weeks |
| DIETARY_SUPPLEMENT | Placebo | Placebo 250 mg/day for 8 weeks |
Timeline
- Start date
- 2024-12-04
- Primary completion
- 2025-12-30
- Completion
- 2025-12-31
- First posted
- 2024-10-08
- Last updated
- 2025-06-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06630455. Inclusion in this directory is not an endorsement.